Monday, July 9, 2012

Molina Healthcare Pops Up 13% (MOH, NSPH, AMPE, WLP, NFLX)

Molina Healthcare, Inc. (NYSE:MOH) shares climbed 13.39% to $26.16 in the morning hour. The company will report its earnings for the second quarter and six months ended June 30, 2012, after the market closes on Thursday, July 26, 2012. The Company's management will host a conference call and webcast to discuss the earnings release at 5:00 p.m. Eastern time on the same day.

Nanosphere, Inc. (NASDAQ:NSPH) stock gained 8.43% to $3.46 in the early hour after the shares of the company was upgraded by equities researchers at Roth Capital from a “neutral” rating to a “buy” rating in a report issued today.

Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) stock increased 5.42% to $5.02 in the morning hour after the company announced the significant results from their further analysis of its Optina(TM) trial on DME. The Optina(TM) trial, conducted at St Michael Hospital in Canada, was a phase II, placebo-controlled, double-masked study to evaluate the efficacy and safety of a 12-week treatment with oral Optina(TM) in adult patients with Diabetic Macular Edema (DME).

WellPoint, Inc. (NYSE:WLP) shares climbed 3.47% to $61.99 in the early hour after WellPoint Inc and AMERIGROUP Corporation announced that they have entered into a definitive agreement through which WellPoint will acquire Amerigroup. Under the terms of the agreement, WellPoint will pay $92.00 per share in cash to acquire shares of Amerigroup for a transaction value of approximately $4.9 billion. The combined company’s Medicaid footprint will include 19 states.

Netflix, Inc. (NASDAQ:NFLX) shares declined 1.16% to $80.94 in the morning hour. On July 6, 2012, a federal judge granted preliminary approval to Netflix’s $9 million settlement of class-action litigation accusing the company of violating consumer privacy laws. The judge also certified a nationwide class of current and former Netflix subscribers estimated in the tens of millions.

No comments:

Post a Comment

Privacy Policy | Legal Disclaimer